🇺🇸 FDA

Intelligence Platform

Patents

Browse 95 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8563614

Use of treprostinil to treat neuropathic diabetic foot ulcers

United Therapeutics Corporation · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536363

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8497393

Process to prepare treprostinil, the active ingredient in Remodulin®

United Therapeutics Corporation · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450345

Iminosugars and methods of treating viral diseases

United Therapeutics Corporation · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426445

Iminosugars and methods of treating bunyaviral and togaviral diseases

United Therapeutics Corporation · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8410169

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349892

Solid formulations of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8350079

Treprostinil formulation

United Therapeutics Corporation · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252839

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8242305

Process to prepare treprostinil, the active ingredient in remodulin

United Therapeutics Corporation · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8232316

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jul 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999007

Buffer solutions having selective bactericidal activity against gram negative bacteria and

United Therapeutics Corporation · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879909

Use of Treprostinil to treat neuropathic diabetic foot ulcers

United Therapeutics Corporation · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7816560

Long chain n-alkyl compounds and oxa-derivatives thereof

United Therapeutics Corporation · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612093

Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imi

United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544713

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7417070

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7384978

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7199157

Use of treprostinil to improve kidney functions

United Therapeutics Corporation · Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6803386

Prostacyclin derivative containing compositions and methods of using the same for the trea

United Therapeutics Corporation · Granted Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756033

Method for delivering benzindene prostaglandins by inhalation

United Therapeutics Corporation · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521212

Method for treating peripheral vascular disease by administering benzindene prostaglandins

United Therapeutics Corporation · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and meth

United Therapeutics Corporation · Granted Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired